The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The role of combined T cell and NK cell activity in immune checkpoint inhibitor (ICI) therapy in endometrial cancer (EC).
 
Danielle Greenberg
No Relationships to Disclose
 
Patrick Penalosa
No Relationships to Disclose
 
Wen Gu
Employment - Caris Life Sciences
Stock and Other Ownership Interests - Caris Life Sciences
 
Sharon Wu
Employment - Caris Life Sciences
Research Funding - Caris Life Sciences
 
Matthew Oberley
Employment - Caris Life Sciences
Leadership - Caris Life Sciences
Stock and Other Ownership Interests - Caris Life Sciences
Travel, Accommodations, Expenses - Caris Life Sciences
 
Michael Toboni
Consulting or Advisory Role - Caris LIfe Sciences
Research Funding - Exelixis; GlaxoSmithKline; Karyopharm Therapeutics
 
Britt Erickson
Consulting or Advisory Role - Abbvie; Gilead Sciences; GlaxoSmithKline; Lilly; Merck; Natera
 
Krishnansu Tewari
Honoraria - AstraZeneca; Eisai; GlaxoSmithKline; Merck
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Roche/Genentech; Tesaro
Speakers' Bureau - AstraZeneca; Clovis Oncology; Eisai; Genmab; Merck; Roche/Genentech; Tesaro
Research Funding - Abbvie (Inst); Genentech/Roche (Inst); Merck (Inst); Morphotek (Inst); Regeneron (Inst)
Travel, Accommodations, Expenses - Roche/Genentech